Your browser doesn't support javascript.
loading
Nanomedicines: intervention in inflammatory pathways of cancer.
Anwar, Firoz; Naqvi, Salma; Shams, Saiba; Sheikh, Ryan Adnan; Al-Abbasi, Fahad A; Asseri, Amer H; Baig, Mirza Rafi; Kumar, Vikas.
Afiliação
  • Anwar F; Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, 21589, Saudi Arabia. fanwar1@kau.edu.sa.
  • Naqvi S; Department of Biomedical Sciences, College of Medicine, Gulf Medical University, Ajman, United Arab Emirates.
  • Shams S; School of Pharmaceutical Education & Research, (Deemed to be University), New Delhi, 110062, India.
  • Sheikh RA; Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.
  • Al-Abbasi FA; Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.
  • Asseri AH; Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.
  • Baig MR; Department of Clinical Pharmacy & Pharmacotherapeutics. Dubai Pharmacy College for Girls, Po Box 19099, Dubai, United Arab Emirates.
  • Kumar V; Natural Product Drug Discovery Laboratory, Department of Pharmaceutical Sciences, Faculty of Health Sciences, Sam Higginbottom Institute of Agriculture, Technology & Sciences, Allahabad, Uttar Pradesh, India. phvikas@gmail.com.
Inflammopharmacology ; 31(3): 1199-1221, 2023 Jun.
Article em En | MEDLINE | ID: mdl-37060398

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nanopartículas / Neoplasias / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nanopartículas / Neoplasias / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article